Where chromium picolinate is permitted, and what the file must show
Chromium picolinate is a permitted chromium source for food supplements in the EU and the UK, and it is sold in the US as a dietary ingredient; the permission is form-specific, so the label must name the picolinate and the file must show the chromium assay, the contaminant results and the market's label wording. Four checks decide the file: the form is on the list, the contaminants sit under the ceiling, the label names the source, and the claim matches the market. The catalog limits are Pb ≤3, As ≤2, Cd ≤1 and Hg ≤0.1 mg/kg.
Permission, contaminant ceiling, label wording and claim are four separate checks; a permitted form does not make a label or a claim compliant by itself.
The four checks
Four questions are often conflated. Is the exact form on the destination market's permitted list? Which contaminant ceiling applies to the finished supplement? Does the label name the source and declare chromium in the required way? And is the statement on the pack an authorised claim, a structure/function statement, or something that cannot be made?
The answers do not travel together. A form listed in the EU is not automatically in the US file, a finished-product ceiling is not a raw-material specification, and a sentence allowed in one market can be a disease claim in another. The current legal text decides.
European Union
In the EU, chromium picolinate appears in Annex II to Directive 2002/46/EC, as amended by Commission Regulation (EC) No 1170/2009. The listing is form-specific: “chromium picolinate” is the entry, and a generic chromium salt is a different entry. The reference intake for labelling is 40 µg/day under Regulation (EU) No 1169/2011; that is a labelling reference, not a maximum. Member States can set their own maximum levels for chromium in food supplements, so the destination matters.
Labelling follows Directive 2002/46/EC and Regulation (EU) No 1169/2011: the pack is presented as a food supplement, the recommended daily portion and the warning not to exceed it are stated, the varied-diet statement is present, and the pack is kept out of reach of young children. Claims fall under Regulation (EC) No 1924/2006 and the authorised list in Regulation (EU) No 432/2012; only the authorised wording, with its conditions, can be used.
United States
In the US, chromium picolinate is sold as a dietary ingredient with a pre-DSHEA marketing history. The brand should still be able to point to the basis for its own ingredient and supplier, because the history of the article and the identity of the lot are different questions. On the Supplement Facts panel, chromium is declared as the element; the Daily Value for adults and children four and older is 35 µg under 21 CFR 101.9. The picolinate belongs in the ingredient list.
Manufacturing follows the dietary supplement cGMP in 21 CFR 111. A structure/function statement is written and substantiated by the brand, carries the DSHEA disclaimer, and is notified to FDA within 30 days of marketing; a disease claim is outside the framework. Federal law sets no general heavy-metal ceiling for supplements, so Proposition 65 and voluntary standards such as USP <2232> often decide what the brand tests.
United Kingdom
The UK applies a retained version of the EU permitted-forms list. As of this review, chromium picolinate remains on the GB list; the GB nutrition and health claims register, not the EU register, governs the wording, and the labelling rules are the UK versions of the food supplement requirements. Northern Ireland continues to apply the EU regime under the Windsor Framework, so a UK launch can be two files rather than one.
The UK reference intake is 40 µg/day, matching the EU NRV. The permitted-forms list and the claims register can diverge from the EU; read the current GB text before the label is approved, and do not assume an EU-authorised sentence is on the GB register.
The contaminant table
| Contaminant | Catalog limit | EU food supplement ceiling | US federal | UK |
|---|---|---|---|---|
| Lead | ≤3 mg/kg | 3.0 mg/kg | No general limit | 3.0 mg/kg |
| Arsenic | ≤2 mg/kg | No harmonised limit | No general limit | No harmonised limit |
| Cadmium | ≤1 mg/kg | 1.0 mg/kg (3.0 for seaweed or bivalve-based) | No general limit | 1.0 mg/kg |
| Mercury | ≤0.1 mg/kg | 0.10 mg/kg | No general limit | 0.10 mg/kg |
The EU and UK columns are written for the supplement as sold; the catalog column is the raw-material specification. They are not interchangeable. The EU ceilings come from Regulation (EU) 2023/915. The arsenic line is the clearest example: the catalog limit of 2 mg/kg is a customer specification because there is no general EU maximum for arsenic in food supplements. Member States can set their own.
Claims and label wording
No disease-related claim belongs on a chromium picolinate pack. In the EU, a claim must be on the authorised list and must match its conditions; in the US, a structure/function statement must be truthful, substantiated and disclaimed, and a disease claim is not permitted. A statement about the form itself — for example, that the lot is the picolinate — is an identity statement, not a health claim, and it still has to be true on the COA.
Do not use the ingredient name to go beyond the authorised wording, and do not let a certification mark stand in for the substantiation. The label sentence belongs to the brand; the evidence belongs in the brand's file.
The document pack
| Document | What it proves | Who issues it |
|---|---|---|
| Specification | The agreed article and limits | Buyer and supplier |
| Lot COA | The results for this lot | Manufacturer |
| SDS | Handling and hazard information | Manufacturer |
| Allergen statement | Whether a declarable allergen is present | Manufacturer |
| Identity records | IR and HPLC results for the lot | Manufacturer or laboratory |
| Contaminant results | Heavy metals and microbiology | Manufacturer or laboratory |
| Packaging declaration | Food-contact suitability of the pack | Pack supplier |
| Label artwork | Source name, chromium amount and warnings | Brand |
Every document should carry the lot code or point to it. A generic TDS and a lot-specific COA are not a matched pair unless the article, the grade and the pack agree.
What to check before the first order
| Check | Evidence | Red flag |
|---|---|---|
| Form on the list | Annex II or GB list entry for the exact source | “Chromium” with no source |
| Contaminants | COA results against the destination ceiling at the daily dose | A raw-material ceiling pasted onto the finished product |
| Label source | Ingredient list names chromium picolinate | “Chromium” or a different salt |
| Chromium amount | µg and % NRV or % DV | A powder weight presented as the chromium amount |
| Claims | Authorised wording or a disclaimed structure/function statement | A disease claim |
| Documents | Lot code on COA, SDS, spec and label | Generic documents with no lot link |
| Change control | New label and specification for a new source | A purchase-order switch with no label change |
The EU, US and UK notes expand each market; the COA page shows the file's results; the identity page covers the form tests; the chromium picolinate hub carries the specification.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation